Valeriya Kirnos, PA
Physician Assistant · Raleigh, NCNPI 1750678744
Payments from drug & device makers
Across 180 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Novo Nordisk$375
- Lilly USA, LLC$228
- GSK$214
- AstraZeneca$164
- Amgen$140
- plus $928 from 19 others
What the payments were for
- Food & beverage$3,082100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 72 | $1,046 |
| Novo Nordisk | 19 | $375 |
| Lilly USA, LLC | 14 | $228 |
| GSK | 11 | $214 |
| AstraZeneca | 11 | $164 |
| Amgen | 10 | $140 |
| AbbVie | 6 | $138 |
| Boston Scientific | 4 | $135 |
| Boehringer Ingelheim | 6 | $114 |
| Exact Sciences | 4 | $84 |
| Pfizer | 2 | $45 |
| Dexcom, Inc. | 2 | $44 |
| Bayer | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Radius Health, Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Merck | 2 | $37 |
| Eisai Inc. | 2 | $31 |
| Lifescan, Inc. | 1 | $30 |
| IBSA Pharma Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
How this compares
$3,095 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 99 | $130,312 |
| ProliaDenosumab | 45 | $78,637 |
| MounjaroTirzepatide | 36 | $63,231 |
| JardianceEmpagliflozin | 45 | $56,402 |
| TrulicityDulaglutide | 24 | $38,099 |
| FarxigaDapagliflozin Propanediol | 15 | $14,137 |
| Humalog Kwikpen U-100Insulin Lispro | 35 | $11,505 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 49 | $9,259 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $7,603 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $7,213 |
| TradjentaLinagliptin | 16 | $4,775 |
| Novolin N FlexpenInsulin Nph Human Isophane | 20 | $3,708 |
| Novolog FlexpenInsulin Aspart | 11 | $3,570 |
| SynthroidLevothyroxine Sodium | 30 | $2,731 |
| Novolin R FlexpenInsulin Regular, Human | 12 | $2,190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $375 | $130,31299 claims |
| Lilly USA, LLCMounjaro, Trulicity | $228 | $101,33160 claims |
| AmgenProlia | $140 | $78,63745 claims |
| Boehringer IngelheimJardiance, Tradjenta | $114 | $61,17761 claims |
| AstraZenecaFarxiga | $164 | $14,13715 claims |
| GSKBreo Ellipta | $214 | $7,21314 claims |
| AbbVieSynthroid, Armour Thyroid | $138 | $4,02244 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $2,021160 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Raleigh
- Jessica CainRaleigh$77K
- Carrie McGroartyRaleigh$69K
- Jaime BullRaleigh$25K
- Kristina KohuthRaleigh$24K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.